Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Lymphoma, Large B-Cell, Diffuse 28Lymphoma, Mantle-Cell 20Burkitt Lymphoma 18Precursor Cell Lymphoblastic Leukemia-Lymphoma 16Lymphoma, Follicular 13Lymphoma, Non-Hodgkin 10Lymphoma, B-Cell 10Leukemia, Lymphocytic, Chronic, B-Cell 10Lymphoma, B-Cell, Marginal Zone 9Hodgkin Disease 8Leukemia, Myeloid, Acute 6Myelodysplastic Syndromes 5Leukemia, Myelomonocytic, Chronic 5Leukemia, Myeloid, Accelerated Phase 5Leukemia, Biphenotypic, Acute 5Lymphoma, T-Cell 4Lymphoma 4Blast Crisis 4Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 3Leukemia, Myeloid, Chronic-Phase 3Hematologic Neoplasms 3Waldenstrom Macroglobulinemia 2Leukemia, Myelogenous, Chronic, BCR-ABL Positive 2Composite Lymphoma 2Anemia, Refractory, with Excess of Blasts 2Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 1Neoplasm, Residual 1Myeloproliferative Disorders 1Myelodysplastic-Myeloproliferative Diseases 1Mycosis Fungoides 1

Interventions

deltacortene 1Vincristine 1Rituximab 1Prednisone 1Methotrexate 1Hyaluronoglucosaminidase 1Etoposide 1Doxorubicin 1Cyclophosphamide 1CT-P10 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Multi-centric Castleman's Disease × CT-P10 × Clear all
NCT03864419 2024-01-03

Rituximab Hyaluronidase in Combination With Chemotherapy in Treating Aggressive B-cell Lymphoma in Uganda

Fred Hutchinson Cancer Center

Phase 1 Terminated
18 enrolled
Lymphoid

Multi-centric Castleman's Disease, Burkitt Lymphoma, Lymphoma, Large B-Cell, Diffuse

Data powered by HemOnc (CC BY 4.0) Colophon âš¡